Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ISRCTN51793206) titled 'Assessing changes in an inflammation signal (interleukin 1) in vestibular schwannoma' on March 4.
Study Type: Interventional
Study Design:
Non-randomized
Interventional
Design type: Treatment, Imaging, Immunotherapy (Treatment)
Primary Sponsor: University of Manchester
Condition:
Vestibular schwannoma
Cancer
Intervention:
The focus of this study is to validate a panel of biomarkers of response to IL-1 antagonism in patients with VS. Ten patients who are listed for surgical resection of a growing sporadic or NF2-related schwannomatosis (NF2-SWN) will be recruited via the Greater Manchester Skull Base Unit b...